Home Categories Biochemical Engineering Abemaciclib (LY2835219)
A5286812

Abemaciclib (LY2835219) , ≥98% , 1231930-82-7

CAS NO.:1231930-82-7

Empirical Formula: C28H36F2N8O3S

Molecular Weight: 602.699

MDL number: MFCD25562906

Pack Size Price Stock Quantity
5MG RMB119.20 In Stock
10MG RMB183.20 In Stock
25MG RMB351.20 In Stock
50mg RMB559.20 In Stock
100MG RMB799.20 In Stock
250mg RMB1412.80 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

storage temp.  -20°
solubility  Soluble in DMSO (up to at least 25 mg/ml) or in Water (up to at least 25 mg/ml).
form  solid
color  Off-white
Stability: Stable for 1 year from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 1 month.
CAS DataBase Reference 1231930-82-7

Description and Uses

Abemaciclib (1231930-82-7) is a potent and selective CDK4/6 inhibitor (IC50?= 2 nM and 10 nM respectively).1?It caused G1 cell cycle arrest in colo-205 colorectal cells, MDA-MB-361 breast cancer cells, and MV4-11 AML cells. Abemaciclib was also active in several human tumor xenograft models. It displayed efficacy in patients with various solid tumors including breast cancer, non-small cell lung cancer. Glioblastoma, melanoma, colorectal cancer, and hormone receptor-positive breast cancer.2?Abemaciclib induced a T cell inflamed tumor microenvironment and enhanced the efficacy of PD-L1 checkpoint blockade in MCF-7 breast cancer cells.3?FDA approved for the treatment of advanced breast cancers.

N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine is an CDK4/6 protein kinase inhibitor with potential antitumor effects.

Safety

RELATED PRODUCTS